Mehmet Sarıaydın

Mehmet Sarıaydın

Auto-generated profile, based on publicly available information

Mehmet Sarıaydın

Adiyaman Training & Res Hosp, Dept Endocrinol & Metab, Adiyaman, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
Mehmet CelikMehmet Celik
Mehmet Celik
SÖSerhat Özcelik
Serhat Özcelik
SBSüleyman Baş
Süleyman Baş
MSMehmet Sariaydin
Mehmet Sariaydin
MÖMelike Özçelik
Melike Özçelik
HGHulya Gozu
Hulya Gozu
Objective: We aimed to investigate the role of testosterone to estradiol ratio in predicting the effectiveness of human chorionic gonadotropin and testosterone treatments in male hypogonadism. Materials and methods: Thirty-six male patients with hypogonadotropic hypogonadism were included in the study. Seventeen (47.2%) patients received weekly recombinant human choriogonadotropin alpha (hCG) treatment (group-1) and 19 (52.8%) received testosterone replacement therapy (T treatment) every 21 days (group-2). Under these treatments, adequate frequency of morning erection (≥3/week), testosterone to estradiol ratio (T/E), [...] ABSTRACT Objective: We aimed to investigate the role of testosterone to estradiol ratio in predicting the effectiveness of human chorionic gonadotropin and testosterone treatments in male hypogonadism. Materials and methods: Thirty-six male patients with hypogonadotropic hypogonadism were included in the study. Seventeen (47.2%) patients received weekly recombinant human choriogonadotropin alpha (hCG) treatment (group-1) and 19 (52.8%) received testosterone replacement therapy (T treatment) every 21 days (group-2). Under these treatments, adequate frequency of morning erection (≥3/week), testosterone to estradiol ratio (T/E),

1 January 2020 in Turkish Journal of Emergency Medicine
Verified
Journal Article
Open access
SÖSerdar Özdemir
Serdar Özdemir
AAAbdullah Algin
Abdullah Algin
MSMehmet Sarıaydın
Mehmet Sarıaydın
MEMehmetÖzgür Erdoğan
MehmetÖzgür Erdoğan
IIIbrahim Inan
Ibrahim Inan
Polycystic liver disease (PLD) develops due to embryonic ductal plate malformation of intrahepatic bile ducts. Cysts in the liver can range from a simple compression effect to severe liver failure. The most common complication is rupture and inflammation of cyst. It can sometimes progress to the extent of pushing the heart to the left or compressing the inferior vena cava, thereby reducing the venous return. Here, we present a case with giant liver cyst-related symptoms that caused external compression of the right ventricle and atrium. A 71-year-old female patient was admitted to our emergency department with increasing dyspnea, chest pain, and abdominal distension. Her vital signs were as follows: temperature 38°C, pulse 140 beats/min, and blood pressure 70/40 mmHg. Her abdomen was distended, and there was minimal epigastric tenderness. Hepatomegaly was also present. Posteroanterior chest radiography revealed opacity that erased the right diaphragm contour at the right inferior hemithorax. In thoracoabdominal computed tomography, the heart was deviated toward the left due to the compression of a large cystic formation located in the hepatic right lobe, pushing the diaphragm to the superior. Piperacillin/tazobactam 3 g × 4.5 g treatment was initiated, and external drainage was performed by interventional radiology. Following this procedure, significant improvement was observed in the patient's condition. Her symptoms significantly improved, and the drainage catheter was removed on the seventh day. Hepatic cysts in patients with PLD may compress adjacent structures, and cardiac compression can be life-threatening if hemodynamic instability occurs.

13 January 2023 in Life and Medical Sciences
Verified
Journal Article
Closed access
SASefer - ASLAN
Sefer - ASLAN
MŞMehmet Şirik
Mehmet Şirik
MSMehmet Sarıaydın
Mehmet Sarıaydın
RÖRamazan İlYas Öner
Ramazan İlYas Öner
In this study, we aimed to determine whether the presence and duration of diabetes mellitus (DM) is ‎associated with changes in intervertebral disc degeneration, epiphyseal plaque degeneration, and ‎subcutaneous fat tissue thickness. Diabetic patients and non-diabetic participants (control group) who applied to the ‎internal medicine outpatient clinic between 2020-2022 and had lumbar spine magnetic resonance imaging ‎due to low back and/or leg pain were included the study. Disc degeneration, epiphyseal plaque ‎degeneration, and subcutaneous fat tissue thickness parameters of DM patients and control group were ‎reviewed retrospectively, and the results were statistically evaluated. There were 80 DM patients in the ‎patient group, 25 (31.3%) of these patients were male and 55 (68.8%) were female. There was a total of ‎‎121 participants in the control group, of which 39 (32.2%) were male and 82 (67.8%) were female. The ‎mean age of the patient group was 57.85±10.76 years, while the mean age of the control group was ‎‎54.23±13.09 years. There was no significant difference between the duration of DM and disc degeneration, ‎epiphyseal plaque degeneration, and subcutaneous adipose tissue thickness. However, there was a ‎significant difference between the control group and the DM patient group in terms of disc degeneration and ‎epiphyseal plaque degeneration (p=0.003 and p=0.017, respectively). This study reveals that patients with ‎diabetes have an increased susceptibility to disc degeneration and epiphyseal plaque degeneration, ‎regardless of disease duration. Control and treatment of diabetic disease will make an important contribution ‎to the prevention of secondary complications‎.